MarginsXMarginsX
Home › Markets › Health Care › NXGL

NexGel Inc (NXGL)

NXGL trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.93
+2.08% on the day
Market cap
$1.9M
Nano cap
Revenue · 2025
$11.4M
+31.5% on 2024
Net income · 2025
-$3.0M
-26.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1468929/000149315226014377/0001493152-26-014377-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNXGL on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2021
SEC CIK0001468929
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$11.4M
Net income-$3.0M
Operating income-$3.4M
Net margin-26.3%
Operating margin-29.3%
Revenue growth+31.5%
Cash$317K
Total assets$10.5M
P/E (computed)Net income was not positive
P/S (computed)0.2×

Warning signs

Cash runway
6.4 months
$1.7M cash at June 30, 2026
Share count, 1 year
+20.8%
2025-08-12 to 2026-08-14 · +71.1% over 3 years
Going-concern doubt
Yes
10-Q filed August 17, 2026
Insider net buying, 12 months
-$77K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-08-17
Cash and burn$1.7M cash; operating cash flow -$801K a quarter.Report 2026-06-30
Shares outstanding487,383 (2026-08-14); 8,067,580 a year earlier; 5,696,064 three years earlier.Cover page 2026-08-14
Reverse splits, 3 years1; latest 1-for-20 on 2026-10-12Source 2026-10-12
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedownsLatest 2026-02-10
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-04-24
AuditorTurner, Stone & Company, L.L.P., Dallas, Texas, United StatesPCAOB Form AP 2026-04-10
Late filings, 12 months1 NT noticeNT 10-Q 2026-08-17
Insider trades, 12 monthsBought $0, sold $77K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$3.7M-$3.6M-$2.2M$1.7M$3.2M$12.1M10-Q 2026-08-17
Q1 2026
2026-03-31
$2.6M-$927K-$504K$2.1M$563K$11.3M10-Q 2026-05-14
Q4 2025
2025-12-31
$2.8M-$970K$281K$317K$588K$11.4M10-K 2026-03-31
Q3 2025
2025-09-30
$2.9M-$653K-$785K$938K$614K$11.7M10-Q 2025-11-12
Q2 2025
2025-06-30
$2.9M-$665K-$407K$725K$638K$11.7M10-Q 2026-08-17
Q1 2025
2025-03-31
$2.8M-$712K-$400K$1.2M$662K$10.2M10-Q 2026-05-14
Q4 2024
2024-12-31
$3.0M-$850K-$859K$1.8M$685K$8.7M10-K 2026-03-31
Q3 2024
2024-09-30
$2.9M-$693K-$1.2M$1.1M$1.1M$6.7M10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12026-08-20
Latest annual report10-K/A2026-04-30
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-12
Latest proxyDEF 14A2026-08-24

Source: SEC EDGAR submissions feed, 333 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+7.8%
1 month-4.2%
3 months-60.3%
Year to date-88.0%
1 year-89.8%
From 52-week high-89.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
NXGLWNexGel Inc Warrant$0.0065

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
AMIXAutonomix Medical Inc.$1.10-19.71%$2.2M
CODXCo-Diagnostics Inc.$0.2249-13.03%$2.4M
BJDXBluejay Diagnostics Inc.$2.29-12.26%$2.6M
ICCMIceCure Medical Ltd.$0.7601+4.12%$2.6M
IVFINVO Fertility Inc.$2.40-7.69%$2.8M
VVOSVivos Therapeutics Inc.$0.0822-16.12%$2.8M
XAIRBeyond Air Inc.$2.02-5.16%$3.4M
TNONTenon Medical Inc.$1.33-5.32%$3.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier